AbbVie: A Compelling Buy
AbbVie: A Compelling Buy.....»»
AbbVie: Still A Compelling Buy?
AbbVie: Still A Compelling Buy?.....»»
AbbVie: A Compelling Buy
AbbVie: A Compelling Buy.....»»
AbbVie looks to Skyrizi, other drugs to replace blockbuster Humira sales
Sales of Skyrizi and Rinvoq jumped in the first quarter for AbbVie, while Humira sales slid......»»
Ex-Humira Growth Platform Drives AbbVie"s Q1 Performance, Drugmaker Lifts Annual Profit Outlook
AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains. read more.....»»
AbbVie"s Dermatitis Drug Shown "Superior" To Sanofi/Regeneron"s Dupixent In Head-To-Head Study
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent. read more.....»»
Thoughts on Leadership: Lessons from Robert Kraft’s Playbook
This past weekend while at home in northern California, I immersed myself in the audiobook version of “The Dynasty” by Jeff Benedict, a compelling chronicle of the New England Patriots’ rise .....»»
AbbVie-Roche Win European Approval for Venclyxto in Newly Diagnosed Acute Myeloid Leukemia
read more.....»»
AbbVie announces new European approval for VENCLYXTO combination
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Olema selloff brings "compelling" entry point, says JPMorgan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie analyses show risankizumab achieves clinical remission in study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie Phase 3 Rinvoq data published in The Lancet
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
VF Corp. current levels provide compelling entry point, says Baird
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Stifel ups price target for "most compelling" theme park Six Flags to $59
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Piper "incrementally bullish" on Biohaven, AbbVie migraine drugs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie Inflated Prices For Two Major Drugs, Engaged In Anticompetitive Practices, House Oversight Report Says
read more.....»»
U.S. House committee chairs call on FTC to launch inquiry of AbbVie"s Humira
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
House Oversight Committee chair asks FTC to probe AbbVie drug pricing
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Lumentum risk/reward "compelling" after selloff, says B. Riley
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ackman says Domino"s "a very compelling story"
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»